This article was last updated on April 16, 2022
Canada: 
Oye! Times readers Get FREE $30 to spend on Amazon, Walmart…
USA: Oye! Times readers Get FREE $30 to spend on Amazon, Walmart…
A key organization holding potentially ground breaking information regarding the diluted chemotherapy scandal, Medbuy, is scheduled to send its top officials for testifying at the Queen’s Park on Monday. The senior executives representing the bulk purchasing organization, which supplies intravenous drugs to five hospitals, are scheduled to appear under oath before the committee that is investigating how more than 1,200 cancer patients in Ontario and New Brunswick received the weaker-than-prescribed treatments during the past year.
Medbuy previously refused to publicly comment on the news of the drug error that came to light on April 2. An NDP member of the committee, France Gélinas, mentioned that “(the hospitals) bent over backwards to tell us that price had nothing to do with it, but let’s see how the bid came in and let’s see how due diligence was done to make sure that you got a product in the way that the hospitals needed it.”
The faulty chemotherapy treatments were purchased from Marchese Hospital Solutions by Medbuy, i.e. an award-winning pharmacy on James Street North, Hamilton. The legislative committee has been questioning key players in the scandal for almost three weeks, including all four Ontario hospitals and the company that supplied the doses. A Progressive Conservative MPP member of the committee and have also worked as a pharmacist, Jeff Yurek, stated that “I have quite a few questions to ask (Medbuy).” He alleged that “they seem to be the conduit between the hospitals and Marchese, so they seem to know the whole story of what went on.”
Be the first to comment